Identification and validation of an assay predictive of response and prognosis following anthracycline-based chemotherapy for early breast cancer.
Jude M. Mulligan(Queen's University Belfast), Richard D. Kennedy(Queen's University Belfast), Fergus J. Couch(Mayo Clinic), Patrick Johnston(Queen's University Belfast), David Boyle(Queen's University Belfast), Manuel Salto‐Tellez(Queen's University Belfast), Jacqueline A. James(Queen's University Belfast), Gareth Irwin(Queen's University Belfast), Fionnuala A. McDyer(Queen's University Belfast), D. Paul Harkin(Almac (United Kingdom)), Katherine E. Keating(Queen's University Belfast), Laura A. Hill(Queen's University Belfast), Olaide Y. Raji(Queen's University Belfast), Timothy S. Davison, Jennifer E. Quinn(Queen's University Belfast), Paul B. Mullan(Queen's University Belfast), Colin R. James(Queen's University Belfast), Steve Deharo(Queen's University Belfast)
Cited by 0
Related Papers
QuPath: Open source software for digital pathology image analysis
|Scientific Reports|2017|8.9k
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
QuPath: Open source software for digital pathology image analysis
|bioRxiv (Cold Spring Harbor Laboratory)|2017|809
Hydrogen sulfide is a novel mediator of lipopolysaccharide‐induced inflammation in the mouse
|The FASEB Journal|2005|766
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
|JNCI Journal of the National Cancer Institute|2010|716